开云app官网登录入口网页版-官方正版

#复发性卵巢癌#

43篇内容 | 1736人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1349640, encodeId=2ac9134964090, content=<a href='/topic/show?id=b97d425286c' target=_blank style='color:#2F92EE;'>#复发性卵巢癌#</a>, objectTitle=Lancet Oncol：鲁卡帕利可作为BRCA1/2突变的复发性卵巢癌化疗的替代选择, objectType=article, longId=300992, objectId=cea030099207, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cea030099207, replyNumber=0, likeNumber=96, createdTime=2022-03-18, rootId=0, userName=windight, userId=ec9955, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cea030099207, moduleTitle=Lancet Oncol：鲁卡帕利可作为BRCA1/2突变的复发性卵巢癌化疗的替代选择, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=cea030099207)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1349639, encodeId=2e1e1349639db, content=<a href='/topic/show?id=b97d425286c' target=_blank style='color:#2F92EE;'>#复发性卵巢癌#</a>, objectTitle=J Clin Oncol：二次细胞减灭术对铂敏感的复发性卵巢癌患者生存期的影响, objectType=article, longId=299554, objectId=e3252995544f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e3252995544f, replyNumber=0, likeNumber=90, createdTime=2022-02-25, rootId=0, userName=windight, userId=ec9955, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e3252995544f, moduleTitle=J Clin Oncol：二次细胞减灭术对铂敏感的复发性卵巢癌患者生存期的影响, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e3252995544f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1349638, encodeId=16f8134963839, content=<a href='/topic/show?id=b97d425286c' target=_blank style='color:#2F92EE;'>#复发性卵巢癌#</a>, objectTitle=Clin Cancer Res：奥拉帕尼单药维持治疗亚洲铂敏感的复发性卵巢癌患者的疗效, objectType=article, longId=295320, objectId=cf6e295320e6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf6e295320e6, replyNumber=0, likeNumber=95, createdTime=2022-02-10, rootId=0, userName=windight, userId=ec9955, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf6e295320e6, moduleTitle=Clin Cancer Res：奥拉帕尼单药维持治疗亚洲铂敏感的复发性卵巢癌患者的疗效, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=cf6e295320e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1349637, encodeId=09aa134963e18, content=<a href='/topic/show?id=b97d425286c' target=_blank style='color:#2F92EE;'>#复发性卵巢癌#</a>, objectTitle=Ann Oncol：3期| 尼拉帕利维持治疗铂敏感性复发性卵巢癌中国患者的疗效, objectType=article, longId=293027, objectId=84b729302ea0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=84b729302ea0, replyNumber=0, likeNumber=58, createdTime=2021-12-30, rootId=0, userName=windight, userId=ec9955, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=84b729302ea0, moduleTitle=Ann Oncol：3期| 尼拉帕利维持治疗铂敏感性复发性卵巢癌中国患者的疗效, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=84b729302ea0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1349636, encodeId=adf9134963602, content=<a href='/topic/show?id=b97d425286c' target=_blank style='color:#2F92EE;'>#复发性卵巢癌#</a>, objectTitle=NEJM：细胞减灭术后化疗可显著改善复发性卵巢癌患者预后, objectType=article, longId=221456, objectId=362222145662, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=362222145662, replyNumber=0, likeNumber=117, createdTime=2021-12-04, rootId=0, userName=windight, userId=ec9955, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=362222145662, moduleTitle=NEJM：细胞减灭术后化疗可显著改善复发性卵巢癌患者预后, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=362222145662)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1349635, encodeId=ac9513496358e, content=<a href='/topic/show?id=b97d425286c' target=_blank style='color:#2F92EE;'>#复发性卵巢癌#</a>, objectTitle=JCO：复发性卵巢癌可否从二次减瘤术时卡铂腹腔热灌注化疗中获益？, objectType=article, longId=211980, objectId=f93f211980ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f93f211980ae, replyNumber=0, likeNumber=88, createdTime=2021-05-30, rootId=0, userName=windight, userId=ec9955, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f93f211980ae, moduleTitle=JCO：复发性卵巢癌可否从二次减瘤术时卡铂腹腔热灌注化疗中获益？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=f93f211980ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1349634, encodeId=675c134963434, content=<a href='/topic/show?id=b97d425286c' target=_blank style='color:#2F92EE;'>#复发性卵巢癌#</a>, objectTitle= 重磅！国内最佳治疗铂敏感及铂耐药复发性卵巢癌的PARP抑制剂帕米帕利获批, objectType=article, longId=210714, objectId=1c60210e1466, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c60210e1466, replyNumber=0, likeNumber=112, createdTime=2021-05-02, rootId=0, userName=windight, userId=ec9955, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c60210e1466, moduleTitle= 重磅！国内最佳治疗铂敏感及铂耐药复发性卵巢癌的PARP抑制剂帕米帕利获批, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=1c60210e1466)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1349633, encodeId=d20b134963373, content=<a href='/topic/show?id=b97d425286c' target=_blank style='color:#2F92EE;'>#复发性卵巢癌#</a>, objectTitle=CLIN CANCER RES：一种新的治疗组合——NUC-1031联合卡铂治疗复发性卵巢癌, objectType=article, longId=208795, objectId=2961208e956a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2961208e956a, replyNumber=0, likeNumber=84, createdTime=2021-03-22, rootId=0, userName=windight, userId=ec9955, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2961208e956a, moduleTitle=CLIN CANCER RES：一种新的治疗组合——NUC-1031联合卡铂治疗复发性卵巢癌, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=2961208e956a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1349632, encodeId=78c61349632de, content=<a href='/topic/show?id=b97d425286c' target=_blank style='color:#2F92EE;'>#复发性卵巢癌#</a>, objectTitle=Lancet oncol：二次减瘤术对于铂敏感的复发性卵巢癌到底有无益处？, objectType=article, longId=208242, objectId=c6c320824279, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6c320824279, replyNumber=0, likeNumber=85, createdTime=2021-03-12, rootId=0, userName=windight, userId=ec9955, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6c320824279, moduleTitle=Lancet oncol：二次减瘤术对于铂敏感的复发性卵巢癌到底有无益处？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=c6c320824279)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1349631, encodeId=826b13496311f, content=<a href='/topic/show?id=b97d425286c' target=_blank style='color:#2F92EE;'>#复发性卵巢癌#</a>, objectTitle=ESMO Open：西地尼布联合化疗治疗复发性卵巢癌的3期试验结果, objectType=article, longId=207454, objectId=c0a120e454b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0a120e454b7, replyNumber=0, likeNumber=90, createdTime=2021-02-24, rootId=0, userName=windight, userId=ec9955, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0a120e454b7, moduleTitle=ESMO Open：西地尼布联合化疗治疗复发性卵巢癌的3期试验结果, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=c0a120e454b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1349628, encodeId=fbca1349628c1, content=<a href='/topic/show?id=b97d425286c' target=_blank style='color:#2F92EE;'>#复发性卵巢癌#</a>, objectTitle=复发性卵巢癌：帕博利珠单抗联合贝伐珠单抗和环磷酰胺治疗安全有效, objectType=article, longId=206110, objectId=c0bd206110aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0bd206110aa, replyNumber=0, likeNumber=127, createdTime=2021-01-24, rootId=0, userName=windight, userId=ec9955, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0bd206110aa, moduleTitle=复发性卵巢癌：帕博利珠单抗联合贝伐珠单抗和环磷酰胺治疗安全有效, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=c0bd206110aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1349630, encodeId=05361349630a1, content=<a href='/topic/show?id=b97d425286c' target=_blank style='color:#2F92EE;'>#复发性卵巢癌#</a>, objectTitle=复发性卵巢癌：Rucaparib 维持治疗优势分析, objectType=article, longId=206094, objectId=3892206094de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3892206094de, replyNumber=0, likeNumber=89, createdTime=2021-01-24, rootId=0, userName=windight, userId=ec9955, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3892206094de, moduleTitle=复发性卵巢癌：Rucaparib 维持治疗优势分析, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=3892206094de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1349629, encodeId=eaea134962990, content=<a href='/topic/show?id=b97d425286c' target=_blank style='color:#2F92EE;'>#复发性卵巢癌#</a>, objectTitle=【瞩目】铂敏感复发性卵巢癌：卡铂-多柔比星-贝伐珠单抗或许是新的标准治疗方案, objectType=article, longId=206078, objectId=28d22060e857, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28d22060e857, replyNumber=0, likeNumber=71, createdTime=2021-01-24, rootId=0, userName=windight, userId=ec9955, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28d22060e857, moduleTitle=【瞩目】铂敏感复发性卵巢癌：卡铂-多柔比星-贝伐珠单抗或许是新的标准治疗方案, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=28d22060e857)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1349627, encodeId=cfe4134962e74, content=<a href='/topic/show?id=b97d425286c' target=_blank style='color:#2F92EE;'>#复发性卵巢癌#</a>, objectTitle=铂敏感复发性卵巢癌维持治疗：如何选择？, objectType=article, longId=206059, objectId=48ca206059f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=48ca206059f4, replyNumber=0, likeNumber=93, createdTime=2021-01-24, rootId=0, userName=windight, userId=ec9955, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=48ca206059f4, moduleTitle=铂敏感复发性卵巢癌维持治疗：如何选择？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=48ca206059f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1349626, encodeId=d32b134962602, content=<a href='/topic/show?id=b97d425286c' target=_blank style='color:#2F92EE;'>#复发性卵巢癌#</a>, objectTitle=BRCA1/2突变铂敏感型复发性卵巢癌：奥拉帕利较非铂化疗能有效改善PFS, objectType=article, longId=206058, objectId=87ad20605893, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87ad20605893, replyNumber=0, likeNumber=82, createdTime=2021-01-24, rootId=0, userName=windight, userId=ec9955, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87ad20605893, moduleTitle=BRCA1/2突变铂敏感型复发性卵巢癌：奥拉帕利较非铂化疗能有效改善PFS, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=87ad20605893)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1349625, encodeId=0df113496253c, content=<a href='/topic/show?id=b97d425286c' target=_blank style='color:#2F92EE;'>#复发性卵巢癌#</a>, objectTitle=Ann Oncol：3期| 尼拉帕利维持治疗铂敏感性复发性卵巢癌中国患者的疗效, objectType=article, longId=205851, objectId=3ac1205851bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3ac1205851bd, replyNumber=0, likeNumber=69, createdTime=2021-01-20, rootId=0, userName=windight, userId=ec9955, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3ac1205851bd, moduleTitle=Ann Oncol：3期| 尼拉帕利维持治疗铂敏感性复发性卵巢癌中国患者的疗效, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=3ac1205851bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1349624, encodeId=40ab134962497, content=<a href='/topic/show?id=b97d425286c' target=_blank style='color:#2F92EE;'>#复发性卵巢癌#</a>, objectTitle=妇瘤探案 | 82岁/BRCAwt/心梗后，奥拉帕利维持治疗对高龄复发性卵巢癌患者有显效，PFS超22个月！, objectType=article, longId=204483, objectId=c6282044830a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6282044830a, replyNumber=0, likeNumber=81, createdTime=2020-12-15, rootId=0, userName=windight, userId=ec9955, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6282044830a, moduleTitle=妇瘤探案 | 82岁/BRCAwt/心梗后，奥拉帕利维持治疗对高龄复发性卵巢癌患者有显效，PFS超22个月！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=c6282044830a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1349623, encodeId=2f1e1349623b6, content=<a href='/topic/show?id=b97d425286c' target=_blank style='color:#2F92EE;'>#复发性卵巢癌#</a>, objectTitle=Br J Cancer：贝洛替康与拓扑替康治疗复发性卵巢癌的2b期临床研究, objectType=article, longId=201975, objectId=b6072019e52f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b6072019e52f, replyNumber=0, likeNumber=78, createdTime=2020-10-12, rootId=0, userName=windight, userId=ec9955, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b6072019e52f, moduleTitle=Br J Cancer：贝洛替康与拓扑替康治疗复发性卵巢癌的2b期临床研究, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=b6072019e52f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1349622, encodeId=afd513496226e, content=<a href='/topic/show?id=b97d425286c' target=_blank style='color:#2F92EE;'>#复发性卵巢癌#</a>, objectTitle=Gynecol Oncol：依维莫司和贝伐单抗在复发性卵巢癌，腹膜癌和输卵管癌中的II期研究, objectType=article, longId=197252, objectId=947b19e25234, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=947b19e25234, replyNumber=0, likeNumber=63, createdTime=2020-07-10, rootId=0, userName=爆笑小医, userId=395f25, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=947b19e25234, moduleTitle=Gynecol Oncol：依维莫司和贝伐单抗在复发性卵巢癌，腹膜癌和输卵管癌中的II期研究, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=947b19e25234)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1349621, encodeId=05471349621e9, content=<a href='/topic/show?id=b97d425286c' target=_blank style='color:#2F92EE;'>#复发性卵巢癌#</a>, objectTitle=Lancet oncol：ARIEL3试验：Rucaparib维持治疗铂敏感性复发性卵巢癌超过2年后的探索性分析, objectType=article, longId=195598, objectId=203c1955983f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=203c1955983f, replyNumber=0, likeNumber=78, createdTime=2020-06-11, rootId=0, userName=windight, userId=ec9955, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=203c1955983f, moduleTitle=Lancet oncol：ARIEL3试验：Rucaparib维持治疗铂敏感性复发性卵巢癌超过2年后的探索性分析, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=203c1955983f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

复发性卵巢癌

2020-05-29

windight (审核中...)

前往app查看评论内容

#复发性卵巢癌#

Lancet Oncol：鲁卡帕利可作为BRCA1/2突变的复发性卵巢癌化疗的替代选择

2022-03-18

windight (审核中...)

前往app查看评论内容

#复发性卵巢癌#

J Clin Oncol：二次细胞减灭术对铂敏感的复发性卵巢癌患者生存期的影响

2022-02-25

windight (审核中...)

前往app查看评论内容

#复发性卵巢癌#

Clin Cancer Res：奥拉帕尼单药维持治疗亚洲铂敏感的复发性卵巢癌患者的疗效

2022-02-10

windight (审核中...)

前往app查看评论内容

#复发性卵巢癌#

Ann Oncol：3期| 尼拉帕利维持治疗铂敏感性复发性卵巢癌中国患者的疗效

2021-12-30

windight (审核中...)

前往app查看评论内容

#复发性卵巢癌#

NEJM：细胞减灭术后化疗可显著改善复发性卵巢癌患者预后

2021-12-04

windight (审核中...)

前往app查看评论内容

#复发性卵巢癌#

JCO：复发性卵巢癌可否从二次减瘤术时卡铂腹腔热灌注化疗中获益？

2021-05-30

windight (审核中...)

前往app查看评论内容

#复发性卵巢癌#

重磅！国内最佳治疗铂敏感及铂耐药复发性卵巢癌的PARP抑制剂帕米帕利获批

2021-05-02

windight (审核中...)

前往app查看评论内容

#复发性卵巢癌#

CLIN CANCER RES：一种新的治疗组合——NUC-1031联合卡铂治疗复发性卵巢癌

2021-03-22

windight (审核中...)

前往app查看评论内容

#复发性卵巢癌#

Lancet oncol：二次减瘤术对于铂敏感的复发性卵巢癌到底有无益处？

2021-03-12

windight (审核中...)

前往app查看评论内容

#复发性卵巢癌#

ESMO Open：西地尼布联合化疗治疗复发性卵巢癌的3期试验结果

2021-02-24

windight (审核中...)

前往app查看评论内容

#复发性卵巢癌#

复发性卵巢癌：帕博利珠单抗联合贝伐珠单抗和环磷酰胺治疗安全有效

2021-01-24

windight (审核中...)

前往app查看评论内容

#复发性卵巢癌#

复发性卵巢癌：Rucaparib 维持治疗优势分析

2021-01-24

windight (审核中...)

前往app查看评论内容

#复发性卵巢癌#

【瞩目】铂敏感复发性卵巢癌：卡铂-多柔比星-贝伐珠单抗或许是新的标准治疗方案

2021-01-24

windight (审核中...)

前往app查看评论内容

#复发性卵巢癌#

铂敏感复发性卵巢癌维持治疗：如何选择？

2021-01-24

windight (审核中...)

前往app查看评论内容

#复发性卵巢癌#

BRCA1/2突变铂敏感型复发性卵巢癌：奥拉帕利较非铂化疗能有效改善PFS

2021-01-24

windight (审核中...)

前往app查看评论内容

#复发性卵巢癌#

Ann Oncol：3期| 尼拉帕利维持治疗铂敏感性复发性卵巢癌中国患者的疗效

2021-01-20

windight (审核中...)

前往app查看评论内容

#复发性卵巢癌#

妇瘤探案 | 82岁/BRCAwt/心梗后，奥拉帕利维持治疗对高龄复发性卵巢癌患者有显效，PFS超22个月！

2020-12-15

windight (审核中...)

前往app查看评论内容

#复发性卵巢癌#

Br J Cancer：贝洛替康与拓扑替康治疗复发性卵巢癌的2b期临床研究

2020-10-12

爆笑小医 (审核中...)

前往app查看评论内容

#复发性卵巢癌#

Gynecol Oncol：依维莫司和贝伐单抗在复发性卵巢癌，腹膜癌和输卵管癌中的II期研究

2020-07-10

windight (审核中...)

前往app查看评论内容

#复发性卵巢癌#

Lancet oncol：ARIEL3试验：Rucaparib维持治疗铂敏感性复发性卵巢癌超过2年后的探索性分析

2020-06-11

科室
- - 订阅+
  - 更多科室
工具
服务